SearchDictionaryMobileLogin

Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.

AbstractEight male, normolipidemic, non-obese subjects were given fenofibrate (F) (300 mg daily) for eight days (period F). After a wash-out period of four weeks, phenobarbital (P) (100 mg daily) was given for eight days (period P). At the end of this period, P was continued at the same dosage but F (300 mg daily) was added and both drugs were given simultaneously for a further eight-day period (period P + F). The plasma concentrations of lipids and the plasma activities of enzymes involved in the interconversion of plasma lipoproteins: lipoprotein lipase (LPL), hepatic lipase (HL) and lecithin: cholesterol acyltransferase (LCAT) were measured before and at the end of each period of treatment. Fenofibrate induced a decrease in the plasma concentration of triglycerides (TG), total cholesterol (TC), apoB and an increase in the plasma activities of LPL and LCAT. Phenobarbital induced a decrease in the plasma concentration of TC, HDL-C and LDL-C (with an unchanged HDL-C/LDL-C ratio) and in the plasma activity of LPL. Addition of P to F did not modify the hypolipidemic action of F but the increase of LPL activity during period P + F was found to be greater than that observed during period F. It is concluded that P does not modify the serum lipoprotein pattern in a way which can be considered as beneficial in terms of atherosclerosis. By measuring the serum concentration of unconjugated bilirubin, the plasma clearance of antipyrine and the urinary excretion of 6 beta-hydroxycortisol as parameters of hepatic microsomal induction, F appeared to be a slight inducer as compared with P. Thus, enzyme induction cannot explain the changes in serum lipoproteins induced by P and does not modify the hypolipidemic action of F.
AuthorsF R Heller, J P Desager, C Harvengt (Affiliation: Laboratory of Pharmacotherapy, Catholic University of Louvain, Brussels, Belgium.)
JournalInternational journal of clinical pharmacology, therapy, and toxicology (Int J Clin Pharmacol Ther Toxicol) Vol. 26 Issue 3 Pg. 138-42 (Mar 1988) ISSN: 0174-4879 GERMANY, WEST
PMID3410596 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antilipemic Agents
  • Lipids
  • Propionates
  • fenofibric acid
  • Procetofen
  • Phenobarbital
  • Antipyrine
  • Phosphatidylcholine-Sterol O-Acyltransferase
  • Lipase
  • Lipoprotein Lipase
Topics
  • Adult
  • Antilipemic Agents (pharmacology)
  • Antipyrine (blood)
  • Enzyme Induction (drug effects)
  • Humans
  • Lipase (blood)
  • Lipids (blood)
  • Lipoprotein Lipase (blood)
  • Liver (enzymology)
  • Male
  • Microsomes, Liver (enzymology)
  • Phenobarbital (pharmacology)
  • Phosphatidylcholine-Sterol O-Acyltransferase (metabolism)
  • Procetofen (analogs & derivatives, pharmacology)
  • Propionates (pharmacology)